People: Parithosh K. Tungaturthi, Ph.D., Patent Agent

Photo of Parithosh K. Tungaturthi, Ph.D., Patent Agent

Parithosh K. Tungaturthi, Ph.D.

Patent Agent

Washington, D.C.
Direct: (202) 828-3547
0
Parithosh K. Tungaturthi is a patent agent in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington, D.C. office. With over 12 years of experience, Dr. Tungaturthi focuses his practice in the areas of patent prosecution, due diligence and opinion work, including drafting novelty, freedom-to-operate, and invalidity opinions. Dr. Tungaturthi’s practice also includes Hatch-Waxman litigation and FDA Regulatory and Compliance matters.
 
Dr. Tungaturthi has significant expertise in a broad range of disciplines including antibody engineering and therapeutics, cancer immunology, molecular diagnostics, genetic engineering, stem cell technology, pharmaceuticals, active pharmaceutical ingredients, formulations, drug delivery, vaccines, medical devices, and plant breeding and biotechnology. He also has experience in nanotechnology, polymer chemistry, organic and inorganic chemistry, biomaterial, and biofuels.
 
Prior to joining the firm, Dr. Tungaturthi worked at prominent law firms the in Washington, D.C. area and as a USPTO examiner.
 
Dr. Tungaturthi earned his J.D. from The University of Baltimore School of Law. He received his Ph.D. in Molecular Biology and Immunology from Thomas Jefferson University and is a graduate of Louisiana State University, where he received his B.S. in Microbiology and conducted research in Organic Chemistry. Dr. Tungaturthi’s undergraduate and graduate research studies have been published in peer-reviewed scientific journals.
 
Prior to entering the field of intellectual property law, Dr. Tungaturthi served as a post-doctoral fellow in the HIV and AIDS Malignancy Branch of National Cancer Institute at the National Institutes of Health. He was also a research associate in the analytical chemistry division of a start-up biotech company.
 
Parithosh K. Tungaturthi is a patent agent in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington, D.C. office. With over 12 years of experience, Dr. Tungaturthi focuses his practice in the areas of patent prosecution, due diligence and opinion work, including drafting novelty, freedom-to-operate, and invalidity opinions. Dr. Tungaturthi’s practice also includes Hatch-Waxman litigation and FDA Regulatory and Compliance matters.
 
Dr. Tungaturthi has significant expertise in a broad range of disciplines including antibody engineering and therapeutics, cancer immunology, molecular diagnostics, genetic engineering, stem cell technology, pharmaceuticals, active pharmaceutical ingredients, formulations, drug delivery, vaccines, medical devices, and plant breeding and biotechnology. He also has experience in nanotechnology, polymer chemistry, organic and inorganic chemistry, biomaterial, and biofuels.
 
Prior to joining the firm, Dr. Tungaturthi worked at prominent law firms the in Washington, D.C. area and as a USPTO examiner.
 
Dr. Tungaturthi earned his J.D. from The University of Baltimore School of Law. He received his Ph.D. in Molecular Biology and Immunology from Thomas Jefferson University and is a graduate of Louisiana State University, where he received his B.S. in Microbiology and conducted research in Organic Chemistry. Dr. Tungaturthi’s undergraduate and graduate research studies have been published in peer-reviewed scientific journals.
 
Prior to entering the field of intellectual property law, Dr. Tungaturthi served as a post-doctoral fellow in the HIV and AIDS Malignancy Branch of National Cancer Institute at the National Institutes of Health. He was also a research associate in the analytical chemistry division of a start-up biotech company.
 

Education

  • J.D., The University of Baltimore School of Law

  • Ph.D. in Molecular Biology and Immunology, Thomas Jefferson University

  • B.S. in Microbiology, Louisiana State University

Admissions

  • Registered Patent Agent, U.S. Patent and Trademark Office

Affiliations

  • Licensing Executive Society (LES)
  • American Intellectual Property Law Association (AIPLA)
  • American Bar Association (ABA)

Presentations

  • "9th Conference on Retroviruses and Opportunistic Infections," Seattle, WA (February 2002)
  • “Retroviruses,” Cold Spring Harbor, NY (May 2001)

Publications

Legal Publications

  • “Momenta v. Teva – Effective Claiming of Methods of Testing Drug Products,” BioLoquitur Life Sciences Blog (December 21, 2015)
  • “Unraveling the Riddle, Solving the Mystery and Comprehending the Enigma: Amgen Inc. v. Sandoz Inc.,” BioLoquitur Life Sciences Blog (November 3, 2015)
  • “Torrent v. Apotex: Secondary Indicia Insufficient to Counter Obviousness of Gilenya at PTAB,” BioLoquitur Life Sciences Blog (October 13, 2015)

Scientific Publications

  • Co-Author, “The role of Vpr in the regulation of HIV-1 gene expression,” Cell Cycle (2006)
  • Co-Author, “Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication,” Virology (2004)
  • Co-Author, “HIV-1 Vpr: Genetic diversity and functional features from the perspective of structure,”  DNA and Cell Biology (2004)
  • Co-Author, “Role of HIV-1 Vpr in AIDS Pathogenesis: relevance and implications of intravirion, intracellular and free Vpr,” Biomedicine and Pharmacotherapy (2003)
  • Co-Author, “Virion-associated HIV-1 Vpr: Variable amount of virus particles derived from cells upon virus infection of proviral DNA transfection,”  Virology (2001)
  • Co-Author, “Synthesis of N-∝-Boc- benz[f]tryptophan: an intrinsic/extrinsic fluorescence probe,” Pept. Proc. Am. Pept. Symp. (1999)
  • Co-Author, “Benz[f]tryptophan, a bathochromic analog of tryptophan, synthesis of its N-∝-t-Boc derivative,” Tetrahedron Letters (1997)

Accolades

  • Patent Examining Function (Office of Patent Quality Assurance, USPTO), 2006
  • Cancer Research Training Award (National Cancer Institute), 2004-2005
  • Thomas Jefferson University Alumni Travel Fellowship, 2000-2003
  • Research Training Grant in Cancer Immunology (National Cancer Institute), 2000-2003
  • Thomas Jefferson University Foerderer Fellowship, 1998-2000